Enazadrem is used in medical research, particularly in studies on dermatological conditions such as psoriasis, due to its ability to inhibit the enzyme phosphodiesterase type 4 (PDE4), which is involved in inflammation and immune system function. This mechanism helps manage skin disorders by reducing inflammatory responses. Additionally, ongoing studies explore its potential for treating other chronic inflammatory diseases, though it remains in the experimental and clinical research stages.